Cellular identity crisis: Antiandrogen resistance by lineage plasticity

Daniel Tuerff; Tristan Sissung; William D. Figg

doi:10.1080/15384047.2017.1323599

Cellular identity crisis: Antiandrogen resistance by lineage plasticity

Daniel Tuerff, Tristan Sissung, William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

A recent publication in Science demonstrates the ability of prostate cancer cells to switch lineages from one that is dependent on androgen signaling to a cell type that is not. Known as lineage plasticity, this phenomenon is driven by the transcription factor SOX2 in RB1 and TP53-deficient prostate cancer. SOX2 is a potential prognostic marker and therapeutic target in castration resistant prostate cancer.

Original language	English
Pages (from-to)	841-842
Number of pages	2
Journal	Cancer Biology and Therapy
Volume	18
Issue number	11
DOIs	https://doi.org/10.1080/15384047.2017.1323599
State	Published - 2 Nov 2017
Externally published	Yes

Keywords

CRPC
Lineage plasticity
RB1
SOX2
TP53
antiandrogen
prostate cancer

Access to Document

10.1080/15384047.2017.1323599

Cite this

@article{2c5e21b46030442fbfbb5a26f366ff9d,

title = "Cellular identity crisis: Antiandrogen resistance by lineage plasticity",

abstract = "A recent publication in Science demonstrates the ability of prostate cancer cells to switch lineages from one that is dependent on androgen signaling to a cell type that is not. Known as lineage plasticity, this phenomenon is driven by the transcription factor SOX2 in RB1 and TP53-deficient prostate cancer. SOX2 is a potential prognostic marker and therapeutic target in castration resistant prostate cancer.",

keywords = "CRPC, Lineage plasticity, RB1, SOX2, TP53, antiandrogen, prostate cancer",

author = "Daniel Tuerff and Tristan Sissung and Figg, {William D.}",

note = "Publisher Copyright: {\textcopyright} 2017, This article not subject to US copyright law.",

year = "2017",

month = nov,

day = "2",

doi = "10.1080/15384047.2017.1323599",

language = "English",

volume = "18",

pages = "841--842",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

publisher = "Taylor and Francis Ltd.",

number = "11",

}

TY - JOUR

T1 - Cellular identity crisis

T2 - Antiandrogen resistance by lineage plasticity

AU - Tuerff, Daniel

AU - Sissung, Tristan

AU - Figg, William D.

PY - 2017/11/2

Y1 - 2017/11/2

N2 - A recent publication in Science demonstrates the ability of prostate cancer cells to switch lineages from one that is dependent on androgen signaling to a cell type that is not. Known as lineage plasticity, this phenomenon is driven by the transcription factor SOX2 in RB1 and TP53-deficient prostate cancer. SOX2 is a potential prognostic marker and therapeutic target in castration resistant prostate cancer.

AB - A recent publication in Science demonstrates the ability of prostate cancer cells to switch lineages from one that is dependent on androgen signaling to a cell type that is not. Known as lineage plasticity, this phenomenon is driven by the transcription factor SOX2 in RB1 and TP53-deficient prostate cancer. SOX2 is a potential prognostic marker and therapeutic target in castration resistant prostate cancer.

KW - CRPC

KW - Lineage plasticity

KW - RB1

KW - SOX2

KW - TP53

KW - antiandrogen

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85031913998&partnerID=8YFLogxK

U2 - 10.1080/15384047.2017.1323599

DO - 10.1080/15384047.2017.1323599

M3 - Article

C2 - 28475401

AN - SCOPUS:85031913998

SN - 1538-4047

VL - 18

SP - 841

EP - 842

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

IS - 11

ER -

Cellular identity crisis: Antiandrogen resistance by lineage plasticity

Abstract

Keywords

Access to Document

Fingerprint

Cite this